Biosimilar DMARDs: What Does the Future Hold? Filipe AraújoJoão GonçalvesJoão Eurico Fonseca Current Opinion 03 March 2016 Pages: 629 - 637
The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date Till SeilerGrit HutterMartin Dreyling Leading Article 06 April 2016 Pages: 639 - 646
Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives Maria D. DonovanBrendan T. GriffinGeraldine B. Boylan Review Article 04 March 2016 Pages: 647 - 661
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis Ennio LubranoFabio Massimo Perrotta Review Article 08 March 2016 Pages: 663 - 673
Nail Psoriasis: A Review of Treatment Options Marcel C. Pasch Review Article Open access 04 April 2016 Pages: 675 - 705
Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures Matt ShirleySohita Dhillon Adis Drug Evaluation 07 April 2016 Pages: 707 - 717
Sublingual Sufentanil: A Review in Acute Postoperative Pain James E. Frampton Adis Drug Evaluation 11 April 2016 Pages: 719 - 729
Erratum to: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion Working Group Nientemale DEIR. VellucciP. Romualdi Erratum 07 April 2016 Pages: 731 - 732